Markets

Market Nav

News Details

01/04/2026 17:30

Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding Its Innovative Portfolio. RYALTRIS is Glenmark's first innovative product introduced into the U.S. Market.